Ben Harman, Senior Director, Target ID & Validation at Immunome, Inc.

Ben Harman

Senior Director, Target ID & Validation at Immunome, Inc. | Greater Philadelphia, United States

Profile last verified August 2026
Biotechnology Verified Profile Greater Philadelphia, United States University of Birmingham
Verified

Personal Email

***@yahoo.com

Personal • High Confidence

Phone Number

215*****

United States • Mobile

Free account · No credit card · 5 profiles/month

Ben Harman Socials
Ben Harman Work Experience

Senior Director, Target ID & Validation at Immunome, Inc. in November 2020 - Present

Director, Target ID & Validation at Immunome, Inc. in February 2020 - November 2020

Director, Hybridoma Generation at Immunome, Inc. in August 2017 - February 2020

See more See less

Principal Scientist, B Cell Biology at Immunome, Inc. in February 2017 - August 2017

Senior Scientist at Janssen Inc. in February 2014 - February 2017

Research Scientist at Johnson & Johnson in January 2009 - February 2014

Ben Harman Education

University of Birmingham, Doctor of Philosophy (PhD)

University of Liverpool, Bachelor’s Degree

Ben Harman Skills
Analytical Skills Problem Solving Communication Biologics Drug Development Oncology Repertoire Project Management Cancer Immunotherapy Innate Immunity
See more See less
Immunology Flow Cytometry Cell Culture Cell In Vitro Drug Discovery Cell Biology Antibodies Assay Development In Vivo Immunoassays Monoclonal Antibodies High Throughput Screening ELISA Cell Based Assays Biotechnology Life Sciences Molecular Biology Tumor Immunology Lung cancer Pharmaceutical Industry
About Ben Harman’s Current Company
Immunome, Inc.

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge targeted cancer therapies, including antibody-drug conjugate therapies (ADCs). Our most advanced pipeline programs are varegacestat (formerly AL102), a gamma secretase inhibitor which is currently in a Phase 3 trial for treatment of desmoid tumors; IM-1021, a ROR1-targeted ADC which is currently in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand, which recently received IND clearance. Our pipeline also includes IM-1617, IM-1335, and IM-1340, all of which are preclinical ADCs pursuing undisclosed targets with expression in multiple solid tumors.

Discover more about Immunome, Inc.
Ben Harman’s Colleagues
Ramya Chandrasekaran

Ramya Chandrasekaran

Seattle, Washington, United States

Senior Scientist, Immuno-Oncology

Senior Scientist - Immunology & Biology at Immunome, Inc.
(November 2023 – Present)

Bob Lapetina

Bob Lapetina

Collegeville, Pennsylvania, United States

VP, FP&A

VP, FP&A at CG Oncology
(May 2024 – Present)

Chris Nicolescu

Chris Nicolescu

Collegeville, Pennsylvania, United States

Antibody Engineering Research Scientist at Immunome, Inc.

Antibody Engineering Research Scientist at Immunome, Inc.
(January 2022 – Present)

Christina Blackwell

Christina Blackwell

Allentown, Pennsylvania, United States

Senior Research Scientist at Immunome

Senior Research Scientist, Target Biology at Immunome, Inc.
(March 2024 – Present)

Bryan Severyn

Bryan Severyn

United States

Senior Scientist at Immunome Inc.

Senior Research Scientist at Immunome, Inc.
(March 2023 – Present)

Antonio Polley

Antonio Polley

Downingtown, Pennsylvania, United States

Principal Scientist at Immunome

Principal Scientist at Immunome, Inc.
(January 2023 – Present)

Search similar profiles
Frequently asked questions about Ben Harman

What is Ben Harman email address?

Email Ben Harman at [email protected], [email protected], [email protected] and [email protected]. This email is the most updated Ben Harman's email found in 2026.

What is Ben Harman phone number?

Ben Harman phone number is 2156271090.

How to contact Ben Harman?

To contact Ben Harman send an email to [email protected], [email protected], [email protected] or [email protected]. If you want to call Ben Harman try calling on 2156271090.

What company does Ben Harman work for?

Ben Harman works for Immunome, Inc..

What is Ben Harman's role at Immunome, Inc.?

Ben Harman is Senior Director, Target ID & Validation

What industry does Ben Harman work in?

Ben Harman works in the Biotechnology industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free